Investment
Features
FeesSafety
Academy
More
Pluang+

Bitcoin buying advised 500 days before April 2028 halving, with a key buy signal expected in Q4 2026

Analyst Insights
21 Sep 2026
Zycrypto
View Source
Bullish
Bitcoin buying advised 500 days before April 2028 halving, with a key buy signal expected in Q4 2026

Market analyst CryptoGoos highlights a pattern where smart wallets accumulate Bitcoin about 500 days before each halving event, with the next halving expected in April 2028. This accumulation phase is followed by profit-taking roughly 500 days after the halving. The analyst points to a potential buying opportunity in Q4 2026, based on historical trends of increased accumulation during deep market dips around that time. This cycle reflects how institutional investors time their Bitcoin exposure, anticipating price rises after supply cuts from halvings. Traders may consider this framework as a guide, though it is not a guarantee and markets remain volatile.

Bitcoin's halving cycle is the subject, with Pluang market data providing context. For readers following cryptocurrency trends, here is Pluang's market snapshot as of Sep 21, 2026 23:51 WIB: out of 50 major cryptocurrencies, 41 rose and 8 fell today. Notable movers include BAL at Rp16.297 (+11.14%), DOGE at Rp1.720 (+10.82%) with 79% sell order activity, and GRT at Rp416 (+8.80%) with 83% sell order activity.

More News

Boeing faces 737 MAX production delays but analysts see potential 32% stock upside.

Boeing faces 737 MAX production delays but analysts see potential 32% stock upside.

Boeing is experiencing ongoing production challenges with its 737 MAX aircraft, causing delays and a recent 3.7% stock drop. Jefferies lowered its price target to $265, still implying a 32% upside from current prices, reflecting cautious optimism. Ba...

Analyst Insights
Neutral
38 minutes ago
Alkermes' ALKS7290 shows strong early results in ADHD treatment, boosting stock by 2.3%.

Alkermes' ALKS7290 shows strong early results in ADHD treatment, boosting stock by 2.3%.

Alkermes plc's drug ALKS7290 demonstrated significant improvement in ADHD symptoms in a Phase 1b trial, with patients showing a 14- to 19-point gain on a 54-point scale within two weeks. This outperforms typical placebo effects, which range from 6 to...

Market News
Bullish
3 hours ago
BrandPilot AI to attend Marketecture Live 2026, focusing on AI and transparency in digital advertising.

BrandPilot AI to attend Marketecture Live 2026, focusing on AI and transparency in digital advertising.

BrandPilot AI announced its participation in Marketecture Live 2026 in Chicago, an event that gathers advertising, media, and technology professionals to discuss industry developments. The company aims to engage in discussions about artificial intell...

Market News
Neutral
4 hours ago
Meta shares jump 12% on strong early adoption of Muse AI assistant and higher price target

Meta shares jump 12% on strong early adoption of Muse AI assistant and higher price target

Meta Platforms shares surged 12% to $747.91 following early success of its new Muse AI assistant, which topped Apple's US App Store with over 730,000 downloads shortly after launch. Wells Fargo raised Meta's price target to $796, citing strong moment...

Market News
Bullish
4 hours ago
Ventas posts strong Q2 2026 growth, raises full-year guidance on senior housing strength.

Ventas posts strong Q2 2026 growth, raises full-year guidance on senior housing strength.

Ventas reported solid Q2 2026 results with 10% same-store cash NOI growth and 9% normalized FFO/share growth, driven by its dominant senior housing portfolio. Management raised its 2026 FFO/share guidance and acquisition targets, citing a strong bala...

Company Fundamentals
Bullish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App